Free Trial
→ Your book attached (From Profits Run) (Ad)tc pixel Free EVOXW Stock Alerts

Evox Therapeutics (EVOXW) Competitors

Evox Therapeutics logo
$0.35 -0.03 (-8.92%)
As of 05/29/2026 03:57 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

EVOXW vs. SXTPW, DRTSW, APLMW, BIVIW, and CDIOW

Should you buy Evox Therapeutics stock or one of its competitors? MarketBeat compares Evox Therapeutics with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Evox Therapeutics include 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), BioVie (BIVIW), and Cardio Diagnostics (CDIOW). These companies are all part of the "biotechnology" industry.

How does Evox Therapeutics compare to 60 Degrees Pharmaceuticals?

Evox Therapeutics (NASDAQ:EVOXW) and 60 Degrees Pharmaceuticals (NASDAQ:SXTPW) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, media sentiment, risk, valuation, earnings and dividends.

Company Net Margins Return on Equity Return on Assets
Evox TherapeuticsN/A N/A N/A
60 Degrees Pharmaceuticals N/A N/A N/A

In the previous week, Evox Therapeutics and Evox Therapeutics both had 1 articles in the media. 60 Degrees Pharmaceuticals' average media sentiment score of 1.89 beat Evox Therapeutics' score of 1.87 indicating that 60 Degrees Pharmaceuticals is being referred to more favorably in the news media.

Company Overall Sentiment
Evox Therapeutics Very Positive
60 Degrees Pharmaceuticals Very Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Evox TherapeuticsN/AN/AN/AN/AN/A
60 Degrees Pharmaceuticals$1.00MN/AN/AN/AN/A

Summary

60 Degrees Pharmaceuticals beats Evox Therapeutics on 2 of the 2 factors compared between the two stocks.

How does Evox Therapeutics compare to Alpha Tau Medical?

Alpha Tau Medical (NASDAQ:DRTSW) and Evox Therapeutics (NASDAQ:EVOXW) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, earnings, risk, dividends, media sentiment, institutional ownership, analyst recommendations and profitability.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alpha Tau MedicalN/AN/AN/AN/AN/A
Evox TherapeuticsN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Alpha Tau MedicalN/A N/A N/A
Evox Therapeutics N/A N/A N/A

In the previous week, Alpha Tau Medical had 1 more articles in the media than Evox Therapeutics. MarketBeat recorded 2 mentions for Alpha Tau Medical and 1 mentions for Evox Therapeutics. Evox Therapeutics' average media sentiment score of 1.87 beat Alpha Tau Medical's score of 0.43 indicating that Evox Therapeutics is being referred to more favorably in the news media.

Company Overall Sentiment
Alpha Tau Medical Neutral
Evox Therapeutics Very Positive

Summary

Alpha Tau Medical and Evox Therapeutics tied by winning 1 of the 2 factors compared between the two stocks.

How does Evox Therapeutics compare to Apollomics?

Evox Therapeutics (NASDAQ:EVOXW) and Apollomics (NASDAQ:APLMW) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, profitability, earnings, institutional ownership, media sentiment, valuation and risk.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Evox TherapeuticsN/AN/AN/AN/AN/A
Apollomics$8.50MN/AN/AN/AN/A

In the previous week, Evox Therapeutics and Evox Therapeutics both had 1 articles in the media. Evox Therapeutics' average media sentiment score of 1.87 equaled Apollomics'average media sentiment score.

Company Overall Sentiment
Evox Therapeutics Very Positive
Apollomics Very Positive

Company Net Margins Return on Equity Return on Assets
Evox TherapeuticsN/A N/A N/A
Apollomics N/A N/A N/A

Summary

Apollomics beats Evox Therapeutics on 1 of the 1 factors compared between the two stocks.

How does Evox Therapeutics compare to BioVie?

BioVie (NASDAQ:BIVIW) and Evox Therapeutics (NASDAQ:EVOXW) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, earnings, valuation, profitability, media sentiment and dividends.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BioVieN/AN/AN/AN/AN/A
Evox TherapeuticsN/AN/AN/AN/AN/A

In the previous week, BioVie had 1 more articles in the media than Evox Therapeutics. MarketBeat recorded 2 mentions for BioVie and 1 mentions for Evox Therapeutics. Evox Therapeutics' average media sentiment score of 1.87 beat BioVie's score of 0.44 indicating that Evox Therapeutics is being referred to more favorably in the news media.

Company Overall Sentiment
BioVie Neutral
Evox Therapeutics Very Positive

Company Net Margins Return on Equity Return on Assets
BioVieN/A N/A N/A
Evox Therapeutics N/A N/A N/A

Summary

BioVie and Evox Therapeutics tied by winning 1 of the 2 factors compared between the two stocks.

How does Evox Therapeutics compare to Cardio Diagnostics?

Evox Therapeutics (NASDAQ:EVOXW) and Cardio Diagnostics (NASDAQ:CDIOW) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, earnings, media sentiment, valuation, institutional ownership, dividends, analyst recommendations and profitability.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Evox TherapeuticsN/AN/AN/AN/AN/A
Cardio Diagnostics$16.57KN/AN/AN/AN/A

In the previous week, Evox Therapeutics and Evox Therapeutics both had 1 articles in the media. Evox Therapeutics' average media sentiment score of 1.87 equaled Cardio Diagnostics'average media sentiment score.

Company Overall Sentiment
Evox Therapeutics Very Positive
Cardio Diagnostics Very Positive

Company Net Margins Return on Equity Return on Assets
Evox TherapeuticsN/A N/A N/A
Cardio Diagnostics N/A N/A N/A

Summary

Cardio Diagnostics beats Evox Therapeutics on 1 of the 1 factors compared between the two stocks.

Get Evox Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for EVOXW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EVOXW vs. The Competition

Export
MetricEvox TherapeuticsBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$388.04M$55.95B$30.05B
Dividend YieldN/A3.86%2.69%5.33%
P/E RatioN/A3.0721.6326.27
Price / SalesN/A7,203.00565.57116.86
Price / CashN/A13.1343.2256.84
Price / BookN/A85.4810.557.30
Net IncomeN/A-$96.07M$3.56B$337.27M
7 Day Performance3.90%2.02%2.85%3.58%
1 Month Performance-11.26%2.87%4.59%5.71%
1 Year PerformanceN/A96.23%37.62%39.70%

Evox Therapeutics Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EVOXW
Evox Therapeutics
N/A$0.35
-8.9%		N/AN/A$0.00N/AN/AN/A
SXTPW
60 Degrees Pharmaceuticals
N/A$0.05
flat		N/A-36.0%$0.00$1.00MN/A2
DRTSW
Alpha Tau Medical
N/A$2.47
flat		N/A+1,208.4%$0.00N/AN/A80
APLMW
Apollomics
N/A$0.01
flat		N/A-29.8%$0.00$8.50MN/A59
BIVIW
BioVie
N/A$0.33
+7.1%		N/AN/A$0.00N/AN/AN/A

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:EVOXW) was last updated on 5/31/2026 by MarketBeat.com Staff.
From Our Partners
The 1934 playbook
In 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...
American Alternative | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
SpaceX just filed. The clock is ticking.
Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...
The Oxford Club | Sponsoredtc pixel
Read now. Do not delete. You’ve been warned.
Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” P...
Porter & Company | Sponsoredtc pixel
SpaceX will mint billionaires. You won't be one of them.
By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...
Behind the Markets | Sponsoredtc pixel